| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Nov 20, 2025 | QuidelOrtho Corp | CEO | Buy | 97.5 | +23,500 | 134.41% | ✗ | $501.6K |
| May 15, 2025 | May 19, 2025 | QuidelOrtho Corp | CEO | Sell | 97.5 | +11,451 | 189.81% | ✗ | $307.4K |
| Dec 11, 2024 | Dec 13, 2024 | QuidelOrtho Corp | CEO | Buy | 95.0 | +6,033 | 100.00% | ✗ | $249.9K |
| May 23, 2019 | May 24, 2019 | ABBOTT LABORATORIES | President | Sell | 2.5 | -450,062 | -77.49% | ✓ | $34M |
| Feb 28, 2019 | Mar 4, 2019 | ABBOTT LABORATORIES | President | Sell | 17.5 | -30,818 | -19.07% | ✗ | $2.4M |
| Sep 20, 2018 | Sep 21, 2018 | ABBOTT LABORATORIES | President | Sell | 5.0 | -58,200 | -29.84% | ✓ | $4M |
| Jul 24, 2018 | Jul 26, 2018 | ABBOTT LABORATORIES | President | Sell | 20.0 | -15,100 | -9.94% | ✗ | $965.8K |
| Feb 28, 2018 | Mar 2, 2018 | ABBOTT LABORATORIES | President | Sell | 20.0 | -13,529 | -8.18% | ✗ | $819.2K |
| Jan 31, 2018 | Feb 1, 2018 | ABBOTT LABORATORIES | President | Sell | 15.0 | -27,733 | -17.71% | ✓ | $1.7M |
| Nov 17, 2017 | Nov 20, 2017 | ABBOTT LABORATORIES | President | Sell | 17.5 | -23,866 | -15.63% | ✗ | $1.3M |